Update: a briefing outlining the presentations by the speakers has been published.
UPDATED – Agenda: EMA Committee for medicinal products for human use (CHMP) (27 – 30 January 2020)
Have you logged into your account? If you are an OPP customer or have free trial access and you can't view this content please click login at the top of the screen. If you are not an OPP subscriber, create a free account now and get started with 30 days free Enterprise access to read this page and use our range of policy tools. Sign up takes under 2 minutes, the 30 day free access ends automatically, and we don't ask for any credit card details.
Press Release: New pre-commercial procurement on next generation sequencing for oncology
Increasing the use of Next Generation Sequencing (NGS) in oncology requires further cost and technology acceleration to make the best solutions available to all types of patients. In the oncNGS project, 8 health procurers from 5 countries (BE, FR, DE, ES, IT) plan to launch a pre-commercial procurement to develop an NGS tumour-marker analysis kit applicable to all tumour types. The aim is that the kit will include automated data analysis, interpretation and reporting to support decision-making.
Comitology Written Consultation: Standing Committee on medicinal products for human use
Have you logged into your account? If you are an OPP customer or have free trial access and you can't view this content please click login at the top of the screen. If you are not an OPP subscriber, create a free account now and get started with 30 days free Enterprise access to read this page and use our range of policy tools. Sign up takes under 2 minutes, the 30 day free access ends automatically, and we don't ask for any credit card details.
Minutes: Committee for medicinal products for human use (CHMP) (9-12 December 2019)
Have you logged into your account? If you are an OPP customer or have free trial access and you can't view this content please click login at the top of the screen. If you are not an OPP subscriber, create a free account now and get started with 30 days free Enterprise access to read this page and use our range of policy tools. Sign up takes under 2 minutes, the 30 day free access ends automatically, and we don't ask for any credit card details.
UPDATED – Agenda: EMA Paediatric Committee (PDCO) (12-15 November 2019)
Have you logged into your account? If you are an OPP customer or have free trial access and you can't view this content please click login at the top of the screen. If you are not an OPP subscriber, create a free account now and get started with 30 days free Enterprise access to read this page and use our range of policy tools. Sign up takes under 2 minutes, the 30 day free access ends automatically, and we don't ask for any credit card details.
UPDATED – Comitology Written Consultation: Standing Committee on medicinal products for human use
Have you logged into your account? If you are an OPP customer or have free trial access and you can't view this content please click login at the top of the screen. If you are not an OPP subscriber, create a free account now and get started with 30 days free Enterprise access to read this page and use our range of policy tools. Sign up takes under 2 minutes, the 30 day free access ends automatically, and we don't ask for any credit card details.
Agenda: EMA Committee for Advanced Therapies (CAT) (18-20 March 2020)
Have you logged into your account? If you are an OPP customer or have free trial access and you can't view this content please click login at the top of the screen. If you are not an OPP subscriber, create a free account now and get started with 30 days free Enterprise access to read this page and use our range of policy tools. Sign up takes under 2 minutes, the 30 day free access ends automatically, and we don't ask for any credit card details.
UPDATED – European Commission launches EU-wide public consultation on Europe’s Beating Cancer Plan
Update: the deadline for the public consultation has been extended until 7 May 2020.
Today, on World Cancer Day, the European Commission is launching an EU-wide public consultation on Europe’s Beating Cancer Plan. The consultation will help shape the Plan, identify key areas, and explore future action.
CAT monthly report of application procedures, guidelines and related documents on advanced therapies
Have you logged into your account? If you are an OPP customer or have free trial access and you can't view this content please click login at the top of the screen. If you are not an OPP subscriber, create a free account now and get started with 30 days free Enterprise access to read this page and use our range of policy tools. Sign up takes under 2 minutes, the 30 day free access ends automatically, and we don't ask for any credit card details.
OPP Meeting Summary: EP Plenary – Council and Commission statements – Multi-annual Financial Framework (10 March 2020)
Have you logged into your account? If you are an OPP customer or have free trial access and you can't view this content please click login at the top of the screen. If you are not an OPP subscriber, create a free account now and get started with 30 days free Enterprise access to read this page and use our range of policy tools. Sign up takes under 2 minutes, the 30 day free access ends automatically, and we don't ask for any credit card details.
OPP Meeting Summary: EP Plenary – Council and Commission statements – Coronavirus outbreak, state of play and ensuring a coordinated European response to the health, economic and social impact (10 March 2020)
Have you logged into your account? If you are an OPP customer or have free trial access and you can't view this content please click login at the top of the screen. If you are not an OPP subscriber, create a free account now and get started with 30 days free Enterprise access to read this page and use our range of policy tools. Sign up takes under 2 minutes, the 30 day free access ends automatically, and we don't ask for any credit card details.
UPDATED – Agenda: EMA Committee for Advanced Therapies (CAT) (6-8 November 2019)
Have you logged into your account? If you are an OPP customer or have free trial access and you can't view this content please click login at the top of the screen. If you are not an OPP subscriber, create a free account now and get started with 30 days free Enterprise access to read this page and use our range of policy tools. Sign up takes under 2 minutes, the 30 day free access ends automatically, and we don't ask for any credit card details.
Report from the Commission to the European Parliament and the Council: Implementation of the third programme of EU action in the field of health in 2017
Have you logged into your account? If you are an OPP customer or have free trial access and you can't view this content please click login at the top of the screen. If you are not an OPP subscriber, create a free account now and get started with 30 days free Enterprise access to read this page and use our range of policy tools. Sign up takes under 2 minutes, the 30 day free access ends automatically, and we don't ask for any credit card details.
OPP Meeting Summary: Health Council – Exchange of views on COVID-19 (6 March 2020)
A summary of the exchange of views is now available.
UPDATED – Comitology Written Consultation: Standing Committee on medicinal products for human use
Have you logged into your account? If you are an OPP customer or have free trial access and you can't view this content please click login at the top of the screen. If you are not an OPP subscriber, create a free account now and get started with 30 days free Enterprise access to read this page and use our range of policy tools. Sign up takes under 2 minutes, the 30 day free access ends automatically, and we don't ask for any credit card details.
Press Release: Rift Valley Fever – Risk low but EU must remain vigilant
The European Union is not at imminent risk from Rift Valley fever, but developments in neighbouring countries mean that the EU authorities and Member States should strengthen, improve and harmonise their surveillance and response capability as well as their scientific and technical expertise to be better prepared for introduction of the disease.
UPDATED – Agenda: EMA Committee for medicinal products for human use (CHMP) (9 – 12 December 2019)
Have you logged into your account? If you are an OPP customer or have free trial access and you can't view this content please click login at the top of the screen. If you are not an OPP subscriber, create a free account now and get started with 30 days free Enterprise access to read this page and use our range of policy tools. Sign up takes under 2 minutes, the 30 day free access ends automatically, and we don't ask for any credit card details.
UPDATED – Comitology Written Consultation: Standing Committee on medicinal products for human use
Have you logged into your account? If you are an OPP customer or have free trial access and you can't view this content please click login at the top of the screen. If you are not an OPP subscriber, create a free account now and get started with 30 days free Enterprise access to read this page and use our range of policy tools. Sign up takes under 2 minutes, the 30 day free access ends automatically, and we don't ask for any credit card details.
UPDATED – Agenda: EMA Pharmacovigilance Risk Assessment Committee (PRAC) (28-31 October 2019)
Have you logged into your account? If you are an OPP customer or have free trial access and you can't view this content please click login at the top of the screen. If you are not an OPP subscriber, create a free account now and get started with 30 days free Enterprise access to read this page and use our range of policy tools. Sign up takes under 2 minutes, the 30 day free access ends automatically, and we don't ask for any credit card details.
World Rare Disease Day: Statement by Commissioner Stella Kyriakides
Have you logged into your account? If you are an OPP customer or have free trial access and you can't view this content please click login at the top of the screen. If you are not an OPP subscriber, create a free account now and get started with 30 days free Enterprise access to read this page and use our range of policy tools. Sign up takes under 2 minutes, the 30 day free access ends automatically, and we don't ask for any credit card details.
OPP Meeting Summary: Competitiveness Council – European Green Deal – a transition to a climate neutral and circular EU industry (27 February 2020)
Have you logged into your account? If you are an OPP customer or have free trial access and you can't view this content please click login at the top of the screen. If you are not an OPP subscriber, create a free account now and get started with 30 days free Enterprise access to read this page and use our range of policy tools. Sign up takes under 2 minutes, the 30 day free access ends automatically, and we don't ask for any credit card details.
Event: The European Conference on Rare Diseases & Orphan Products (ECRD) (Stockholm, 15 – 16 May 2020)
The event draws together more than 800 participants from over 50 countries around the world. Leading, inspiring and engaging all stakeholders to take action, ECRD is where innovative solutions in the rare disease field are born. The Conference is an unrivalled opportunity to network and exchange invaluable knowledge with all stakeholders in the rare disease community – patient representatives, policy makers, researchers, clinicians, industry representatives, payers and regulators.
Agenda: EMA Paediatric Committee (PDCO) (25 – 28 February 2020)
Have you logged into your account? If you are an OPP customer or have free trial access and you can't view this content please click login at the top of the screen. If you are not an OPP subscriber, create a free account now and get started with 30 days free Enterprise access to read this page and use our range of policy tools. Sign up takes under 2 minutes, the 30 day free access ends automatically, and we don't ask for any credit card details.
PDCO monthly report of opinions on paediatric investigation plans and other activities (28-31 January 2020)
Have you logged into your account? If you are an OPP customer or have free trial access and you can't view this content please click login at the top of the screen. If you are not an OPP subscriber, create a free account now and get started with 30 days free Enterprise access to read this page and use our range of policy tools. Sign up takes under 2 minutes, the 30 day free access ends automatically, and we don't ask for any credit card details.
